ABAX - Abaxis, Inc.

NasdaqGS - NasdaqGS Delayed Price. Currency in USD

Abaxis, Inc.

3240 Whipple Road
Union City, CA 94587
United States
510-675-6500
http://www.abaxis.com

SectorHealthcare
IndustryMedical Laboratories & Research
Full Time Employees584

Key Executives

NameTitlePayExercisedAge
Mr. Clinton H. SeversonChairman & CEO1.2MN/A70
Mr. Donald P. WoodPres & COO814.73kN/A66
Mr. Ross Taylor Jr.CFO, Principal Accounting Officer, VP of Fin. & Sec.645.46kN/A55
Dr. Kenneth P. Aron Ph.D.Chief Technology Officer687.1kN/A65
Dr. Craig M. Tockman DVMVP of Animal Health Sales and Marketing - North America686.99kN/A58
Amounts are as of December 31, 2017 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Abaxis, Inc. develops, manufactures, markets, and sells portable blood analysis systems for use in human or veterinary patient care settings to provide rapid blood constituent measurements for clinicians worldwide. It operates in two segments, Medical Market and Veterinary Market. The company offers Piccolo chemistry analyzers with rapid blood constituent measurements for use in human patient care; and Piccolo profiles that are single-use medical reagents. It also provides VetScan VS2, a chemistry, electrolyte, immunoassay, and blood gas analyzer delivering results from a sample of whole blood, serum, or plasma; VetScan profiles, which are packaged as single-use plastic veterinary reagent discs; and VetScan HM5, VetScan HM2, VetScan HMII, and VetScan HMT hematology instruments, as well as reagent kits for veterinary applications. In addition, the company offers VetScan VSpro that assists the diagnosis and evaluation of suspected bleeding disorders, toxicity/poisoning, disseminated intravascular coagulation evaluation, hepatic disease, monitoring therapy, and disease progression states; VetScan VSpro coagulation test to evaluate prothrombin and the activated partial thromboplastin times; VetScan VSpro fibrinogen test for in-vitro determination of fibrinogen levels in equine platelet poor plasma from a citrated stabilized whole blood sample; and i-STAT that delivers blood gas, electrolyte, chemistry, and hematology results. Further, it provides VetScan rapid tests for the detection of various diseases, as well as sells products developed through its patented Orbos discrete lyophilization process to companies for other applications. The company sells its products through direct sales force and independent distributors. Abaxis, Inc. was founded in 1989 and is headquartered in Union City, California.

Corporate Governance

Abaxis, Inc.’s ISS Governance QualityScore as of January 1, 2018 is 2. The pillar scores are Audit: 2; Board: 6; Shareholder Rights: 1; Compensation: 4.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.